Induced Dopaminergic Neurons for Parkinson's Disease Therapy: Targeting the Striatum or Midbrain/Substantia Nigra Pars Compacta?
10.1007/s12264-022-00829-6
- Author:
Huadong XU
1
;
Xu CHENG
1
;
Qian SONG
2
;
Yuxin YANG
1
;
Changhe WANG
3
;
Xinjiang KANG
4
Author Information
1. Key Laboratory of Medical Electrophysiology, Ministry of Education of China, The Institute of Cardiovascular Research, Southwest Medical University, Luzhou, 646000, China.
2. Neuroscience Research Center, Institute of Mitochondrial Biology and Medicine, Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi'an Jiaotong University, Xi'an, 710049, China.
3. Key Laboratory of Medical Electrophysiology, Ministry of Education of China, The Institute of Cardiovascular Research, Southwest Medical University, Luzhou, 646000, China. changhewang@xjtu.edu.cn.
4. Key Laboratory of Medical Electrophysiology, Ministry of Education of China, The Institute of Cardiovascular Research, Southwest Medical University, Luzhou, 646000, China. kxj335@163.com.
- Publication Type:Research Support, Non-U.S. Gov't
- MeSH:
Corpus Striatum;
Dopaminergic Neurons;
Humans;
Mesencephalon;
Parkinson Disease/drug therapy*;
Pars Compacta;
Substantia Nigra
- From:
Neuroscience Bulletin
2022;38(7):820-824
- CountryChina
- Language:English
